Literature DB >> 28666608

Strict adherence rules to obtain monoclonal therapy might cost lives.

Ruth H Green1, Dominick Shaw2.   

Abstract

Mesh:

Substances:

Year:  2017        PMID: 28666608     DOI: 10.1016/S2213-2600(17)30238-2

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN: 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  6 in total

1.  Adherence to Asthma Biologics: Implications for Patient Selection, Step Therapy, and Outcomes.

Authors:  Jacob T Maddux; Jonathan W Inselman; Molly M Jeffery; Regina W Lam; Nilay D Shah; Matthew A Rank
Journal:  Chest       Date:  2020-10-24       Impact factor: 9.410

2.  Suppression of F ENO with observed inhaled corticosteroid therapy in severe asthma: is it a useful test in clinical practice?

Authors:  Shoaib Faruqi; Sean Zhou; Joanne Thompson; Terry Robinson; Karen Watkins; Helena Cummings; Nicola Jackson; Anoop Prakash; Michael Crooks
Journal:  ERJ Open Res       Date:  2019-11-25

3.  Making the invisible visible: the availability and desirability of adherence data in routine CF care- findings from a national questionnaire survey.

Authors:  Louisa Robinson; Chin Maguire; Zhe Hui Hoo; Martin J Wildman
Journal:  F1000Res       Date:  2019-11-11

4.  Con: Access to advanced therapies for severe asthma should be restricted to patients with satisfactory adherence to maintenance treatment.

Authors:  Ireti Adejumo; Dominick E Shaw
Journal:  Breathe (Sheff)       Date:  2021-06

5.  Pro: Access to advanced therapies for severe asthma should be restricted to patients with satisfactory adherence to maintenance treatment.

Authors:  Anna C Murphy; Claire Boddy; Peter Bradding
Journal:  Breathe (Sheff)       Date:  2021-06

6.  Adherence to omalizumab: A multicenter "real-world" study.

Authors:  Raffaele Campisi; Claudia Crimi; Rossella Intravaia; Simona Strano; Alberto Noto; Maria Pia Foschino; Giuseppe Valenti; Vittorio Viviano; Corrado Pelaia; Luisa Ricciardi; Nicola Scichilone; Nunzio Crimi
Journal:  World Allergy Organ J       Date:  2020-02-12       Impact factor: 4.084

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.